Dr Donal McLornan

Dr Donal McLornan graduated in 1999 from Queen’s University Belfast with Honours. Postgraduate training was completed in Belfast with a further one-year period spent in Hammersmith Hospital, London specialising in allogeneic and autologous stem cell transplantation. During his post-graduate training he was awarded a prestigious MRC fellowship and completed a PhD investigating drug resistance in AML. Donal works as a consultant in the allogeneic transplant and CAR-T team at University College Hospital London, which has the largest combined transplant and cellular therapy program in the UK. He is the current chair of the Chronic Malignancy Working Party of the EBMT (MPN/MDS/CML/CLL/Plasma cell dyscrasia) and is co-chair of the EBMT scientific council. Additionally, he chairs the UK wide National Cancer Research Institute MPN group. He has a particular interest in MPN, MDS/MPN overlap syndromes and allogeneic stem cell transplantation. His research and clinical trial portfolio focuses on Myelofibrosis and blast phase disease and he has published widely on these topics.

MPN MDS STEM CELL TRANSPLANT